A detailed history of Covestor LTD transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Covestor LTD holds 66 shares of KRYS stock, worth $12,566. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66
Previous 66 -0.0%
Holding current value
$12,566
Previous $12,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$153.12 - $183.64 $81,000 - $97,145
-529 Reduced 88.91%
66 $12,000
Q1 2024

May 10, 2024

BUY
$108.01 - $179.35 $216 - $358
2 Added 0.34%
595 $106,000
Q4 2023

Feb 09, 2024

BUY
$96.0 - $128.29 $4,320 - $5,773
45 Added 8.21%
593 $74,000
Q3 2023

Nov 13, 2023

SELL
$108.51 - $130.22 $19,314 - $23,179
-178 Reduced 24.52%
548 $64,000
Q2 2023

Aug 11, 2023

BUY
$78.48 - $130.32 $56,819 - $94,351
724 Added 36200.0%
726 $85,000
Q3 2022

Nov 14, 2022

SELL
$64.85 - $82.4 $129 - $164
-2 Reduced 50.0%
2 $0
Q2 2022

Aug 10, 2022

SELL
$48.93 - $73.47 $48 - $73
-1 Reduced 20.0%
4 $0
Q1 2022

May 13, 2022

SELL
$51.99 - $72.11 $51 - $72
-1 Reduced 16.67%
5 $0
Q4 2021

Feb 10, 2022

BUY
$39.81 - $88.24 $238 - $529
6 New
6 $0

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.89B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.